Page last updated: 2024-11-12

thuringiensin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thuringiensin: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID20056441
SCHEMBL ID118874
MeSH IDM0186845

Synonyms (19)

Synonym
thuringiensin
beta-exotoxin (bacillus thuringiensis)
d-allaric acid, o-5'-deoxyadenosinyl-(5'-4)-o-3,6-anhydro-alpha-d-glucopyranosyl-(1-2)-, 4-(dihydrogenphosphate)
nsc 197177
bacillus thuringiensis exotoxin
thuringiensin a
d-allaric acid, 2-o-alpha-d-glucopyranosyl-, 4-(dihydrogen phosphate), 4'-5'-anhydride with adenosine
thurintox
2-[(2r,3r,4r,5s,6r)-5-[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid
turingin-1 [russian]
unii-jbu770v87c
turingin-1
d-allaric acid, o-5'-deoxyadenosin-5'-yl-(5'.fwdarw.4)-o-alpha-d-glucopyranosyl-(1.fwdarw.2)-, 4-(dihydrogen phosphate)
jbu770v87c ,
SCHEMBL118874
.beta.-exotoxin (bacillus thuringiensis)
d-allaric acid, o-5'-deoxyadenosin-5'-yl-(5'->4)-o-.alpha.-d-glucopyranosyl-(1->2)-, 4-(dihydrogen phosphate
(2r,3s,4s,5s)-2-[(2r,3r,4r,5s,6r)-5-[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid
Q27281428

Research Excerpts

Overview

Thuringiensin is a thermostable secondary metabolite in Bacillus thuringiensis and has insecticidal activity against a wide range of insects.

ExcerptReferenceRelevance
"Thuringiensin is a thermostable secondary metabolite in Bacillus thuringiensis and has insecticidal activity against a wide range of insects. "( Genome-wide screening reveals the genetic determinants of an antibiotic insecticide in Bacillus thuringiensis.
Cao, SY; Hu, ZF; Liu, XY; Liu, Y; Peng, DH; Ruan, LF; Sun, M; Yu, ZN; Zheng, JS, 2010
)
1.8

Toxicity

ExcerptReferenceRelevance
" The strains were of serotype H-1, producing thuringiensin, toxic to flies, and serotype H-14, producing endotoxin, toxic to mosquitoes, but not thuringiensin."( Safety testing of Bacillus thuringiensis preparations, including thuringiensin, using the Salmonella assay.
Abdel-Hameed, AH; Carlberg, G; Tikkanen, L, 1995
)
0.79

Dosage Studied

ExcerptRelevanceReference
" The dosage of 360 units/mL penicillin-G had only a modest effect on the growth of the microorganism."( Penicillin-G enhanced production of thuringiensin by Bacillus thuringiensis sp. darmstadiensis.
Tzeng, YM; Young, YH,
)
0.41
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (26.47)18.2507
2000's20 (58.82)29.6817
2010's5 (14.71)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.16 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]